Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Codex DNA, Inc.

https://codexdna.com/

Latest From Codex DNA, Inc.

Big Pharma Deal Hunters Target RNA Approaches In Race To Build Best Platforms

The potential for RNA medicines to achieve holy grail goals – reaching undruggable targets and bringing drugs to market faster – has Pfizer, Lilly, Novartis and others in a deal-making frame of mind. 

Deals Innovation

Pfizer Shopping For Deals That Will Add $25bn To 2030 Revenues

With cash to spend and a patent cliff to overcome starting in 2025, Pfizer is expected to be a prolific deal-maker in 2022.

Deals Leadership
See All

Company Information

  • Industry
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
  • Biotechnology
    • Drug Discovery Tools
    • Synthesis Technologies, Production Processes
  • Other Names / Subsidiaries
    • SGI-DNA Inc.
    • Synthetic Genomics Solutions
UsernamePublicRestriction

Register